Chie Otsuka
Okayama University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Chie Otsuka.
Journal of Bacteriology | 2005
Masato Otsuka; Makoto Yasuda; Yuji Morita; Chie Otsuka; Tomofusa Tsuchiya; Hiroshi Omote; Yoshinori Moriyama
NorM is a member of the multidrug and toxic compound extrusion (MATE) family and functions as a Na+/multidrug antiporter in Vibrio parahaemolyticus, although the underlying mechanism of the Na+/multidrug antiport is unknown. Acidic amino acid residues Asp32, Glu251, and Asp367 in the transmembrane region of NorM are conserved in one of the clusters of the MATE family. In this study, we investigated the role(s) of acidic amino acid residues Asp32, Glu251, and Asp367 in the transmembrane region of NorM by site-directed mutagenesis. Wild-type NorM and mutant proteins with amino acid replacements D32E (D32 to E), D32N, D32K, E251D, E251Q, D367A, D367E, D367N, and D367K were expressed and localized in the inner membrane of Escherichia coli KAM32 cells, while the mutant proteins with D32A, E251A, and E251K were not. Compared to cells with wild-type NorM, cells with the mutant NorM protein exhibited reduced resistance to kanamycin, norfloxacin, and ethidium bromide, but the NorM D367E mutant was more resistant to ethidium bromide. The NorM mutant D32E, D32N, D32K, D367A, and D367K cells lost the ability to extrude ethidium ions, which was Na+ dependent, and the ability to move Na+, which was evoked by ethidium bromide. Both E251D and D367N mutants decreased Na+-dependent extrusion of ethidium ions, but ethidium bromide-evoked movement of Na+ was retained. In contrast, D367E caused increased transport of ethidium ions and Na+. These results suggest that Asp32, Glu251, and Asp367 are involved in the Na+-dependent drug transport process.
Nucleic Acids Research | 2006
Tetsuya Suzuki; Kei Moriyama; Chie Otsuka; David Loakes; Kazuo Negishi
We have studied the mutagenic properties of ribonucleotide analogues by reverse transcription to understand their potential as antiretroviral agents by mutagenesis of the viral genome. The templating properties of nucleotide analogues including 6-(β-D-ribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c](1,2)oxazin-7-one, N4-hydroxycytidine, N4-methoxycytidine, N4-methylcytidine and 4-semicarbazidocytidine, which have been reported to exhibit ambiguous base pairing properties, were examined. We have synthesized RNA templates using T3 RNA polymerase, and investigated the specificity of the incorporation of deoxyribonucleoside triphosphates opposite these cytidine analogues in RNA by HIV and AMV reverse transcriptases. Except for N4-methylcytidine, both enzymes incorporated both dAMP and dGMP opposite these analogues in RNA. This indicates that they would be highly mutagenic if present in viral RNA. To study the basis of the differences among the analogues in the incorporation ratios of dAMP to dGMP, we have carried out kinetic analysis of incorporation opposite the analogues at a defined position in RNA templates. In addition, we examined whether the triphosphates of these analogues were incorporated competitively into RNA by human RNA polymerase II. Our present data supports the view that these cytidine analogues are mutagenic when incorporated into RNA, and that they may therefore be considered as candidates for antiviral agents by causing mutations to the retroviral genome.
Nucleosides, Nucleotides & Nucleic Acids | 2001
Kei Moriyama; Chie Otsuka; David Loakes; Kazuo Negishi
The nucleoside P can base pair with both A and G. We evaluated the mutation frequency induced by the 5′-triphospbate of the ribonucleoside P (PTP) in an in vitro retroviral replication model. After 4 cycles of replication in the presence of PTP, the mutation frequency was raised to 3.8 × 10−2 per nucleotide and C-to-U and U-to-C mutations were dominantly observed. These results suggest that ambivalent NTP analogues, like PTP, could induce mutations beyond the error threshold of retroviruses.
Mutation Research | 2005
Chie Otsuka; Nozomu Kunitomi; Shigenori Iwai; David Loakes; Kazuo Negishi
Nucleic Acids Research | 2002
Chie Otsuka; Sachi Sanadai; Yasuhiro Hata; Hisanori Okuto; Vladimir N. Noskov; David Loakes; Kazuo Negishi
Mutation Research | 2002
Chie Otsuka; Keita Kobayashi; Naho Kawaguchi; Nozomu Kunitomi; Kei Moriyama; Yoshihiro Hata; Shigenori Iwai; David Loakes; Vladimir N. Noskov; Youri I. Pavlov; Kazuo Negishi
Nucleic acids research. Supplement (2001) | 2002
Chie Otsuka; David Loakes; Kazuo Negishi
Genes and Environment | 2006
Kazuo Negishi; Shoichi Higashi; Takanori Nakamura; Chie Otsuka; Masakatsu Watanabe; Tomoe Negishi
Mutagenesis | 2008
Chin Wei Yung; Yoji Okugawa; Chie Otsuka; Keinosuke Okamoto; Sakae Arimoto; David Loakes; Kazuo Negishi; Tomoe Negishi
Nucleic acids symposium series (2004) | 2005
Tetsuya Suzuki; Toshiyuki Okada; Chie Otsuka; Kei Moriyama; David Loakes; Kazuo Negishi